Free Trial
NASDAQ:BPTH

Bio-Path (BPTH) Stock Price, News & Analysis

Bio-Path logo
$0.16 -0.01 (-6.03%)
As of 07/7/2025 03:47 PM Eastern

About Bio-Path Stock (NASDAQ:BPTH)

Key Stats

Today's Range
$0.16
$0.17
50-Day Range
$0.14
$0.22
52-Week Range
$0.12
$3.39
Volume
14,362 shs
Average Volume
988,618 shs
Market Capitalization
$1.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bio-Path Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

BPTH MarketRank™: 

Bio-Path scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Bio-Path.

  • Earnings Growth

    Earnings for Bio-Path are expected to grow in the coming year, from ($3.34) to ($1.55) per share.

  • Price to Book Value per Share Ratio

    Bio-Path has a P/B Ratio of 0.23. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bio-Path's valuation and earnings.
  • Percentage of Shares Shorted

    0.81% of the float of Bio-Path has been sold short.
  • Short Interest Ratio / Days to Cover

    Bio-Path has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bio-Path has recently decreased by 5.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bio-Path does not currently pay a dividend.

  • Dividend Growth

    Bio-Path does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.81% of the float of Bio-Path has been sold short.
  • Short Interest Ratio / Days to Cover

    Bio-Path has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bio-Path has recently decreased by 5.86%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 1 people have searched for BPTH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bio-Path insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.72% of the stock of Bio-Path is held by insiders.

  • Percentage Held by Institutions

    Only 5.74% of the stock of Bio-Path is held by institutions.

  • Read more about Bio-Path's insider trading history.
Receive BPTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter.

BPTH Stock News Headlines

Bio-Path Holdings, Inc. (BPTH) - Yahoo Finance
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

BPTH Stock Analysis - Frequently Asked Questions

Bio-Path's stock was trading at $1.16 at the start of the year. Since then, BPTH shares have decreased by 86.2% and is now trading at $0.1605.

Bio-Path Holdings, Inc. (NASDAQ:BPTH) released its quarterly earnings results on Thursday, August, 15th. The company reported ($1.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.54) by $0.38.
Read the conference call transcript
.

Bio-Path shares reverse split on Friday, February 23rd 2024.The 1-20 reverse split was announced on Friday, February 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of BPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bio-Path investors own include NVIDIA (NVDA), Canopy Growth (CGC), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU), Anavex Life Sciences (AVXL) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
8/15/2024
Today
7/07/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BPTH
Fax
N/A
Employees
10
Year Founded
2007

Price Target and Rating

Average Stock Price Target
$20.00
High Stock Price Target
$20.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+12,361.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
0.23

Miscellaneous

Free Float
5,726,000
Market Cap
$1.33 million
Optionable
Optionable
Beta
-0.03

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:BPTH) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners